Registration Dossier
Registration Dossier
Data platform availability banner - registered substances factsheets
Please be aware that this old REACH registration data factsheet is no longer maintained; it remains frozen as of 19th May 2023.
The new ECHA CHEM database has been released by ECHA, and it now contains all REACH registration data. There are more details on the transition of ECHA's published data to ECHA CHEM here.
Diss Factsheets
Use of this information is subject to copyright laws and may require the permission of the owner of the information, as described in the ECHA Legal Notice.
EC number: 700-903-6 | CAS number: 255830-15-0
- Life Cycle description
- Uses advised against
- Endpoint summary
- Appearance / physical state / colour
- Melting point / freezing point
- Boiling point
- Density
- Particle size distribution (Granulometry)
- Vapour pressure
- Partition coefficient
- Water solubility
- Solubility in organic solvents / fat solubility
- Surface tension
- Flash point
- Auto flammability
- Flammability
- Explosiveness
- Oxidising properties
- Oxidation reduction potential
- Stability in organic solvents and identity of relevant degradation products
- Storage stability and reactivity towards container material
- Stability: thermal, sunlight, metals
- pH
- Dissociation constant
- Viscosity
- Additional physico-chemical information
- Additional physico-chemical properties of nanomaterials
- Nanomaterial agglomeration / aggregation
- Nanomaterial crystalline phase
- Nanomaterial crystallite and grain size
- Nanomaterial aspect ratio / shape
- Nanomaterial specific surface area
- Nanomaterial Zeta potential
- Nanomaterial surface chemistry
- Nanomaterial dustiness
- Nanomaterial porosity
- Nanomaterial pour density
- Nanomaterial photocatalytic activity
- Nanomaterial radical formation potential
- Nanomaterial catalytic activity
- Endpoint summary
- Stability
- Biodegradation
- Bioaccumulation
- Transport and distribution
- Environmental data
- Additional information on environmental fate and behaviour
- Ecotoxicological Summary
- Aquatic toxicity
- Endpoint summary
- Short-term toxicity to fish
- Long-term toxicity to fish
- Short-term toxicity to aquatic invertebrates
- Long-term toxicity to aquatic invertebrates
- Toxicity to aquatic algae and cyanobacteria
- Toxicity to aquatic plants other than algae
- Toxicity to microorganisms
- Endocrine disrupter testing in aquatic vertebrates – in vivo
- Toxicity to other aquatic organisms
- Sediment toxicity
- Terrestrial toxicity
- Biological effects monitoring
- Biotransformation and kinetics
- Additional ecotoxological information
- Toxicological Summary
- Toxicokinetics, metabolism and distribution
- Acute Toxicity
- Irritation / corrosion
- Sensitisation
- Repeated dose toxicity
- Genetic toxicity
- Carcinogenicity
- Toxicity to reproduction
- Specific investigations
- Exposure related observations in humans
- Toxic effects on livestock and pets
- Additional toxicological data
Endpoint summary
Administrative data
Description of key information
An acute oral toxicity study, conducted according to a standard acute toxicity method and in compliance with GLP, concluded an LD50 value of ≥5000 mg/kg bw/day based on no deaths up to the highest dose tested (RBM 1991a).
An acute dermal toxicity study, conducted according to a standard acute toxicity method and in compliance with GLP, concluded an LD50 value of ≥2000 mg/kg bw/day based on no deaths up to the highest dose tested (RBM, 1991b).
There is no inhalation study available, however, since oral and dermal route studies are available, the inhalation endpoint is waived.
Key value for chemical safety assessment
Acute toxicity: via oral route
Link to relevant study records
- Endpoint:
- acute toxicity: oral
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 22 January 1991 - 05 February 1991
- Reliability:
- 1 (reliable without restriction)
- Rationale for reliability incl. deficiencies:
- guideline study
- Qualifier:
- according to guideline
- Guideline:
- other: ECC guideline - VI Amendment, Annex V, Directive 84/449/EEC
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Italia S.p.A., Via Indipendenza, 11, 22050 - CALCO (Como)
- Age at study initiation: ca. 7-9 weeks
- Weight at study initiation: 225-250 grams (males), 200-225 grams (females)
- Fasting period before study: 16 hours (Volume of dosing was based on day 1 bodyweight. Feed was returned to rats three hours after the test article administration).
- Housing: 5 animals/sex/cage in air-conditioned rooms, in grill cages with stainless steel feeders.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: Minimum of 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 10 %
- Air changes (per hr): ca. 20 / hour
- Photoperiod (hrs dark / hrs light): 12 hours dark / 12 hours light - Route of administration:
- oral: gavage
- Vehicle:
- water
- Details on oral exposure:
- VEHICLE
Just before the treatment of the animals a weighed amount of the test article was dissolved with the suitable volume of deionized water.
MAXIMUM DOSE VOLUME APPLIED: 10 ml/kg - Doses:
- 5000 mg/kg
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: Observations took place at 30 minutes, 2, 4 and 6 hours on the first day after the administration and then twice a day up to the termination of the observation period. Body weights were taken once pre-trial and on days 1, 3, 8 and 14. On day 1 the animals were weighed after a 16 hour fasting.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Histological examination was not performed as no macroscopic findings emerged from necropsy. - Statistics:
- The LD50 calculation was not possible.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 5 000 mg/kg bw
- Based on:
- dissolved
- Remarks on result:
- other: No adverse effects observed
- Mortality:
- There were no deaths.
- Clinical signs:
- Hypoactivity, shallow breathing, piloerection and hunched posture were the main clinical signs observed starting from 30 minutes and lasting up to 2 days after the test article administration. Recovery of all treated animals was achieved 3 days after treatment.
- Body weight:
- The body weight gain of all the treated animals was considered within normal limits for rats of this strain and age (except for one female rat which showed a slight decrease in body weight gain only at the day 3 weighing).
- Gross pathology:
- No changes were noted in any of the necropsied animals.
- Other findings:
- None reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- An acute oral toxicity study, conducted according to a standard acute toxicity method and in compliance with GLP, concluded an LD50 value of ≥5000 mg/kg bw/day based on no adverse effects.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 5 000 mg/kg bw
- Quality of whole database:
- Klimisch score of 1.
Acute toxicity: via inhalation route
Endpoint conclusion
- Endpoint conclusion:
- no study available
Acute toxicity: via dermal route
Link to relevant study records
- Endpoint:
- acute toxicity: dermal
- Type of information:
- experimental study
- Adequacy of study:
- key study
- Study period:
- 27 November - 12 December 1990
- Reliability:
- 2 (reliable with restrictions)
- Rationale for reliability incl. deficiencies:
- guideline study with acceptable restrictions
- Remarks:
- Information lacking on whether the exposure was occlusive or semi-occlusive.
- Qualifier:
- according to guideline
- Guideline:
- other: EEC guidelines - VI Amendment, Annex V, Directive 84/449/EEC
- Deviations:
- yes
- Remarks:
- Lacking information on whether the exposure was occlusive or semi-occlusive.
- GLP compliance:
- yes
- Test type:
- standard acute method
- Limit test:
- yes
- Species:
- rat
- Strain:
- Sprague-Dawley
- Sex:
- male/female
- Details on test animals or test system and environmental conditions:
- TEST ANIMALS
- Source: Charles River Italia S.p.A., Via Indipendenza, 11, 22050 - CALCO (Como)
- Age at study initiation: ca. 7-9 weeks
- Weight at study initiation: Males: 225 - 250 grams. Females: 200 - 225 grams
- Housing: 1 animal/cage in air conditioned rooms. Grill cages with stainless steel feeder.
- Diet: ad libitum
- Water: ad libitum
- Acclimation period: Minimum of 5 days.
ENVIRONMENTAL CONDITIONS
- Temperature (°C): 22 +/- 2 °C
- Humidity (%): 55 +/- 10 %
- Air changes (per hr): 20 / hour
- Photoperiod (hrs dark / hrs light): 12 hours dark / 12 hours light - Type of coverage:
- not specified
- Vehicle:
- unchanged (no vehicle)
- Details on dermal exposure:
- TEST SITE
- Area of exposure: Dorsal and ventral area of the trunk of the test animals.
- % coverage: 10%
- Type of wrap if used: Not specified. Test report states that the treated area was covered with a porous gauze dressing fixed to the skin with tape and further covered in a 'suitable manner' to ensure that the animals could not ingest test material.
REMOVAL OF TEST SUBSTANCE
- Washing: At the end of the exposure period the test substance was wiped off.
- Time after start of exposure: 24 hours.
TEST MATERIAL
- Amount(s) applied (volume or weight with unit): 2000 mg/kg bw - Duration of exposure:
- Single administration - 24 hour exposure
- Doses:
- 2000 mg/kg
- No. of animals per sex per dose:
- 5 males, 5 females
- Control animals:
- no
- Details on study design:
- - Duration of observation period following administration: 14 days
- Frequency of observations and weighing: The animals were observed on exposure day at 30 minutes, 2, 4 and 6 hours and on the following 14 days twice per day (early in the morning and late in the afternoon. Body weights were taken once pre-trial, on the administration day and on days 8 and 15.
- Necropsy of survivors performed: yes
- Other examinations performed: clinical signs, body weight,organ weights, histopathology, other: Since no changes were found at necropsy, histological examination was not performed. - Statistics:
- Since no mortality occurred at the limit dose of 2000 mg/kg, the LD50 was not calculated.
- Key result
- Sex:
- male/female
- Dose descriptor:
- LD50
- Effect level:
- >= 2 000 mg/kg bw
- Based on:
- test mat.
- Remarks on result:
- other: No adverse effects observed
- Mortality:
- No mortality occurred in the treated animals.
- Clinical signs:
- The rats did not show any clinical signs or change in behaviour and no reaction was observed on the application site.
- Body weight:
- Body weight gain of all rats was considered to be within normal limits for animals of this strain and age.
- Gross pathology:
- No changes were observed in the animals killed at the end of the study.
- Other findings:
- None reported.
- Interpretation of results:
- GHS criteria not met
- Conclusions:
- An acute dermal toxicity study, conducted according to a standard acute toxicity method and in compliance with GLP, concluded an LD50 value of ≥2000 mg/kg bw/day based on no adverse effects observed.
Reference
Endpoint conclusion
- Endpoint conclusion:
- no adverse effect observed
- Dose descriptor:
- LD50
- Value:
- 2 000 mg/kg bw
- Quality of whole database:
- Klimisch score of 2.
Additional information
The available studies were reliable and therefore fulfilled the criteria for selection as key. The test substance for both key studies comprised of 38% salt and 27% active acid at pH 10.
In an acute oral toxicity study, ATMP-N-oxide-5K was administered to ten Sprague-Dawley rats in a single dose by oral gavage with a recovery period for 14 days. The dose was 5000 mg/kg. Clinical signs included hypoactivity, shallow breathing, piloerection and hunched posture starting 30 minutes after administration and lasting up to 2 days after the test article administration. Recovery of all treated animals was achieved 3 days after treatment. An LD50 was concluded to be ≥5000 mg/kg bw/day based on no deaths up to the highest dose tested (RBM 1991a).
In an acute dermal toxicity study, ATMP-N-oxide-5K was administered to ten Sprague-Dawley rats in a single dermal application of 2000 mg/kg. It was concluded that LD50 is ≥2000 mg/kg bw/day based on no deaths up to the highest dose tested (RBM, 1991b).
Acute oral and dermal toxicity data for ATMP-H have been included to support read-across within the ATMP and ATMP-N-Oxide Category. Therefore, these data have not been discussed in detail in this endpoint summary.
In a well-conducted acute oral study with ATMP-H, conducted according to a protocol similar to the now-deleted OECD Test Guideline 401, but not to GLP, an LD50 of 2910 mg/kg bw was determined for ATMP-H in the rat (Younger Laboratories, 1967a).
In a well-conducted acute dermal study with ATMP-H, conducted according to a protocol similar to OECD Test Guideline 402, but not in compliance with GLP, a dermal LD50 of >6310 mg/kg bw was determined for ATMP-H in the rabbit (Younger Laboratories, 1967b).
Justification for classification or non-classification
Based on the available data, no classification for acute toxicity is required for acute toxicity for ATMP-N-oxide-5K in accordance with Regulation (EC) No 1272/2008.
Information on Registered Substances comes from registration dossiers which have been assigned a registration number. The assignment of a registration number does however not guarantee that the information in the dossier is correct or that the dossier is compliant with Regulation (EC) No 1907/2006 (the REACH Regulation). This information has not been reviewed or verified by the Agency or any other authority. The content is subject to change without prior notice.
Reproduction or further distribution of this information may be subject to copyright protection. Use of the information without obtaining the permission from the owner(s) of the respective information might violate the rights of the owner.